Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Locher

Showing results (131-140 of 140) with videos related to

Pageof 14
Sort By:
You have reached the last page of results.This site can display upto 140 results.
Nature Structural & Molecular Biology|April 4, 2018
Structural basis of small-molecule inhibition of human multidrug transporter ABCG2Scott M Jackson, Ioannis Manolaridis, Julia Kowal, et al.
Archives of Pathology & Laboratory Medicine|June 13, 1998
Human immunodeficiency virus-2 infection in baboons is an animal model for human immunodeficiency virus pathogenesis in humansC P Locher, S W Barnett, B G Herndier, et al.
Vaccine|May 20, 2004
Human immunodeficiency virus type 2 DNA vaccine provides partial protection from acute baboon infectionChristopher P Locher, Stephanie A Witt, Brittany M Ashlock, et al.
Plos Pathogens|February 13, 2015
Novel inhibitors of cholesterol degradation in Mycobacterium tuberculosis reveal how the bacterium's metabolism is constrained by the intracellular environmentBrian C VanderVen, Ruth J Fahey, Wonsik Lee, et al.
Antimicrobial Agents and Chemotherapy|December 24, 2014
A novel inhibitor of gyrase B is a potent drug candidate for treatment of tuberculosis and nontuberculosis mycobacterial infectionsChristopher P Locher, Steven M Jones, Brian L Hanzelka, et al.
ACS Chemical Biology|October 24, 2024
Modulation of ABCG2 Transporter Activity by Ko143 DerivativesQin Yu, Sepehr Dehghani-Ghahnaviyeh, Ali Rasouli, et al.
Bioorganic & Medicinal Chemistry Letters|August 6, 2017
2-N-Arylthiazole inhibitors of Mycobacterium tuberculosisMichael P Clark, Tiansheng Wang, Emanuele Perola, et al.
Nature Chemical Biology|March 11, 2026
Structures of ALG3/9/12 reveal the assembly logic of the N-glycan oligomannose coreJ Andrew N Alexander, Shu-Yu Chen, Somnath Mukherjee, et al.
Cell|April 26, 2024
Positive selection CRISPR screens reveal a druggable pocket in an oligosaccharyltransferase required for inflammatory signaling to NF-κBBenjamin L Lampson, Ana S Ramίrez, Marta Baro, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 15, 2007
Directed evolution of gene-shuffled IFN-alpha molecules with activity profiles tailored for treatment of chronic viral diseasesAmy D Brideau-Andersen, Xiaojian Huang, Siu-Chi Chang Sun, et al.
Pageof 14

Showing results (131-140 of 140) with videos related to

Sort By:
Pageof 14
You have reached the last page of results.This site can display upto 140 results.
Nature Structural & Molecular Biology|April 4, 2018
Structural basis of small-molecule inhibition of human multidrug transporter ABCG2Scott M Jackson, Ioannis Manolaridis, Julia Kowal, et al.
Archives of Pathology & Laboratory Medicine|June 13, 1998
Human immunodeficiency virus-2 infection in baboons is an animal model for human immunodeficiency virus pathogenesis in humansC P Locher, S W Barnett, B G Herndier, et al.
Vaccine|May 20, 2004
Human immunodeficiency virus type 2 DNA vaccine provides partial protection from acute baboon infectionChristopher P Locher, Stephanie A Witt, Brittany M Ashlock, et al.
Plos Pathogens|February 13, 2015
Novel inhibitors of cholesterol degradation in Mycobacterium tuberculosis reveal how the bacterium's metabolism is constrained by the intracellular environmentBrian C VanderVen, Ruth J Fahey, Wonsik Lee, et al.
Antimicrobial Agents and Chemotherapy|December 24, 2014
A novel inhibitor of gyrase B is a potent drug candidate for treatment of tuberculosis and nontuberculosis mycobacterial infectionsChristopher P Locher, Steven M Jones, Brian L Hanzelka, et al.
ACS Chemical Biology|October 24, 2024
Modulation of ABCG2 Transporter Activity by Ko143 DerivativesQin Yu, Sepehr Dehghani-Ghahnaviyeh, Ali Rasouli, et al.
Bioorganic & Medicinal Chemistry Letters|August 6, 2017
2-N-Arylthiazole inhibitors of Mycobacterium tuberculosisMichael P Clark, Tiansheng Wang, Emanuele Perola, et al.
Nature Chemical Biology|March 11, 2026
Structures of ALG3/9/12 reveal the assembly logic of the N-glycan oligomannose coreJ Andrew N Alexander, Shu-Yu Chen, Somnath Mukherjee, et al.
Cell|April 26, 2024
Positive selection CRISPR screens reveal a druggable pocket in an oligosaccharyltransferase required for inflammatory signaling to NF-κBBenjamin L Lampson, Ana S Ramίrez, Marta Baro, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 15, 2007
Directed evolution of gene-shuffled IFN-alpha molecules with activity profiles tailored for treatment of chronic viral diseasesAmy D Brideau-Andersen, Xiaojian Huang, Siu-Chi Chang Sun, et al.
Pageof 14